What is the role of cytomegalovirus immune globulin in the treatment of cytomegalovirus (CMV)?

Updated: Jul 07, 2021
  • Author: Ricardo Cedeno-Mendoza, MD; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

CMV immune globulin has been approved by the US Food and Drug Administration for the prophylaxis of CMV disease in high-risk lung transplant recipients when given in conjunction with ganciclovir. In a retrospective study of cardiothoracic transplant recipients, those who received CMV immune globulin plus ganciclovir had a higher disease-free incidence of CMV, less rejection, higher survival rate, and reduced coronary intimal thickening compared with patients who received ganciclovir alone. [80] A prospective randomized study is required to confirm these observations.

CMV immune globulin is used in combination with ganciclovir to treat CMV pneumonia.

See the Medication section for dosing.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!